MAPT and Alzheimer disease: This cohort was previously analyzed for CSF t-tau and phosphorylated tau25 and includes clinically diagnosed cases of AD, sporadic bvFTD, bvFTD secondary to FTLD-MAPT, PSP-RS, CBS and the CBS-PSP continuum26.